Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing.

Adults as young as 50 may now qualify for an RSV vaccine if they have certain health conditions, according to a quiet update ...

Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. "Respiratory ...

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related ...

Respiratory Syncytial Virus. RSV is a single-stranded RNA virus in the Pneumoviridae family and the Orthopneumovirus genus. It was first isolated in 1955 from chimpanzees with respiratory illness ...

Virbac, Westlake, Texas, is expanding its United States cattle range of products with four vaccines—BOVIGEN Platinum 5, BOVIGEN Platinum 5 L5, BOVIGENPlatinum 3 and BOVIGEN Platinum 3 LP Vaccines.

The highly contagious respiratory syncytial virus (RSV) typically causes mild illness, but it can lead to severe respiratory complications, particularly for at-risk individuals. Drawing on local ...

Respiratory syncytial virus (RSV) infections are the leading cause of viral death in infants, although RSV-related mortality has decreased since the development and approval of prophylactic ...

Every year, millions of people worldwide are affected by a virus that often goes unnoticed –Respiratory Syncytial Virus (RSV). Despite its widespread prevalence, many people remain unaware of what RSV ...

RESPIRATORY SYNCYTIAL VIRUS (RSV) is a pneumovirus frequently associated with respiratory illnesses. 1-3 While RSV has been known to cause serious complications in infants and young children, it ...

Electron microscope shows human respiratory syncytial virus (RSV) virions, colourised blue, and anti-RSV F protein/gold antibodies, colourised yellow, shedding from the surface of human lung cells ...

Evaluation of Guillain–Barré syndrome (GBS) following respiratory syncytial virus (RSV) vaccination among adults 65 years and older. Meeting of the Advisory Committee on Immunization Practices (ACIP) ...